SMTL ID : 7jni.1 (1 other biounit)

Crystal structure of the angiotensin II type 2 receptoror (AT2R) in complex with EMA401

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

monomer

Ligands

1 x VFD: Olodanrigan(Non-covalent)

VFD.1: 17 residues within 4Å: Chain A: Y.128, W.177, Y.180, Y.185, G.198, L.201, T.202, M.205, F.206, I.209, R.259, C.272, K.292, W.346, F.349, I.381, F.385 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:Y.128, A:W.177, A:Y.180, A:Y.185, A:L.201, A:M.205, A:F.206, A:F.206, A:I.209, A:K.292, A:K.292, A:W.346, A:W.346, A:F.349, A:I.381, A:F.385 Water bridges: A:R.259 Salt bridges: A:K.292 pi-Stacking: A:F.349

3 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)

OLC.2: 7 residues within 4Å: Chain A: I.298, L.301, I.302, T.306, F.309, K.313 Ligands: OLC.5 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.298, A:L.301, A:I.302 Hydrogen bonds: A:F.309 OLC.5: 6 residues within 4Å: Chain A: L.301, F.309, R.312, I.343, L.347 Ligands: OLC.2 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.309, A:F.309, A:I.343 OLC.6: 10 residues within 4Å: Chain A: E.5, Q.283, A.286, G.287, L.290, I.294, L.295, W.360, M.361 Ligands: OLA.7 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:A.286, A:L.290, A:I.294, A:L.295 Hydrogen bonds: A:E.5

3 x OLA: OLEIC ACID(Non-covalent)

OLA.3: 6 residues within 4Å: Chain A: K.333, A.336, A.337, I.344, V.390 Ligands: OLA.4 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:A.337, A:I.344, A:V.390 Hydrogen bonds: A:K.333 OLA.4: 7 residues within 4Å: Chain A: I.134, M.334, A.337, C.389, V.390, F.393 Ligands: OLA.3 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.134, A:V.390, A:F.393, A:F.393 OLA.7: 5 residues within 4Å: Chain A: L.290, I.294, I.298, F.354 Ligands: OLC.6 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:L.290, A:I.294, A:I.298, A:F.354

1 x FMT: FORMIC ACID(Non-functional Binders)

FMT.8: 9 residues within 4Å: Chain A: M.205, S.208, I.209, I.212, W.346, G.384, N.387, S.388, N.391 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.208, A:G.384, A:N.387, A:N.391

1 x HEZ: HEXANE-1,6-DIOL(Non-covalent)

HEZ.9: 5 residues within 4Å: Chain A: I.103, Q.104, S.109, Y.281, W.360 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.103, A:Q.104, A:Y.281 Hydrogen bonds: A:S.109

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Perryman, R. et al., Inhibition of the angiotensin II type 2 receptor AT 2 R is a novel therapeutic strategy for glioblastoma. Proc.Natl.Acad.Sci.USA (2022)

Release Date

2022-02-09

Peptides

Soluble cytochrome b562,Type-2 angiotensin II receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Soluble cytochrome b562,Type-2 angiotensin II receptor

Related Entries With Identical Sequence